Effect of clinical pathways based on integrative medicine for patients with chronic heart failure: a multi-center research.
- Author:
Xu ZOU
1
;
Guang-Ming PAN
;
Xiao-Gang SHENG
;
Geng-Zhen YAO
;
Ming-Jun ZHU
;
Yang WU
;
Xiao-Hu CHEN
;
Yong-Xia WANG
;
Jie CUI
;
Jian-Dong CHEN
Author Information
- Publication Type:Journal Article
- MeSH: Chronic Disease; Critical Pathways; Heart Failure; nursing; therapy; Hospitalization; economics; Humans; Integrative Medicine; Length of Stay; Patient Satisfaction; Quality of Life; Retrospective Studies; Treatment Outcome
- From: Chinese Journal of Integrated Traditional and Western Medicine 2013;33(6):741-746
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo assess a multi-center study effectiveness of clinical pathways based on integrative medicine (IM) for chronic heart failure (CHF) patients.
METHODSA combined method of historical control study and clinical study on concurrent control was used. After the standard management for clinical pathways was carried out in four hospitals at home, the effects on hospitalization days, medical expenses, clinical efficacy, patient satisfaction, and quality of life were assessed.
RESULTSResults of non-concurrent historical control study showed that: the hospital stay was significantly shorter in the pathways group than in the retrospective group (12.59 days vs 18.44 days), and the total cost of hospitalization was significantly reduced in the pathways group (yen 9 051.90 vs yen 11 978.40), showing statistical difference (P < 0.01). Moreover, the effect on the heart function was better in the pathways group than in the retrospective group (the markedly effective rate: 45.60% vs 21.90%; the total effective rate: 96.80% vs 86.10%), showing statistical difference (P < 0.01). Results of clinical study on concurrent control showed that the hospital stay was significantly shorter in the pathways group than in the control group (11.19 days vs 13.21 days), showing statistical difference (P < 0.05). The average total cost of hospitalization was significantly lower in the pathways group than in the control group (yen 8 656.80 vs yen 11 609.70), showing statistical difference (P < 0.01). As for clinical efficacy of Chinese medical syndrome, the total effective rate was higher in the pathways group than in the control group (97.10% vs 93.62%), showing statistical difference (P < 0.05). The markedly effective rate of heart function was better in the pathways group than in the control group, showing statistical difference (49.30% vs 38.30%, P < 0.05). The overall satisfaction was higher in the pathways group than in the conventional group (P < 0.01). There was no statistical difference in the mortality within 3 months after discharge from hospital, and the readmission rate due to heart failure between the two groups (P > 0.05). But there was statistical difference in the quality of life (P < 0.05).
CONCLUSIONThe pathway could shorten the hospitalization time, decrease the cost of hospitalization, improve the clinical efficacy, improve patients' quality of life and satisfaction, therefore, it could be spread nationwide.